Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Faulty inflammasome activation may lead to autoimmune skin diseases and could be a target for new treatments.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.

FGF21 can help reduce skin inflammation caused by C. acnes.

Mechlorethamine treatment regrew hair in mice by killing immune cells causing hair loss without harming hair follicles.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

A Gsdma3 mutation causes hair loss due to stem cell damage from skin inflammation.

COVID-19 mRNA vaccines may increase the risk of flare-ups in certain inflammatory diseases.

The document concludes that more research is needed to understand and treat Beard Alopecia Areata due to limited current knowledge and evidence.

Anti-TNF-α therapy may increase the risk of developing alopecia areata, especially in those with a history of autoimmune disease.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Intralesional triamcinolone is more effective than cryotherapy for treating alopecia areata in middle-aged adults.

Inflammation damages sweat ducts, causing sweat gland injury.

Skin and hair changes in horses can indicate serious diseases, and recognizing these signs is important for treatment and management.

A man's red tattoo caused a skin reaction and hair loss in his beard, which improved after treatment.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

The document concludes that accurate diagnosis of different types of hair loss requires careful examination of hair and scalp tissue, considering both clinical and microscopic features.

People with atopic dermatitis have more CD4+ T cells that respond to a certain bacterial lipid, which may play a role in the skin condition's inflammation.

Alopecia areata is a common autoimmune condition causing varying hair loss, diagnosed by specific patterns of inflammation around hair follicles, with several treatment options available.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Gamma delta T cells in the skin help with healing and defense but can also cause autoimmune issues, and more research is needed to understand how they are activated.

Urban air pollution worsens hair loss in alopecia areata by increasing immune response.

Panchkarma treatment can help manage symptoms of Systemic Lupus Erythematous.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

The monkey's hair loss was due to an autoimmune disease, not genetics.

Reduced SIRT1 in hair cells may cause alopecia areata by triggering immune responses.

Thyroid and skin autoimmune diseases share genetic and immune links, affecting both tissues.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.